发明名称 |
Method of treating lower urinary tract disorders |
摘要 |
<p>The invention relates to the treatment of at least one symptom of a lower urinary tract disorder in a subject in need of treatment wherein the symptom is selected from the group consisting of urinary frequency, urinary urgency, urinary urge incontinence, nocturia and enuresis, and wherein to a subject in need of treatment a therapeutically effective amount of a compound that has 5-HT<Sub>3</Sub> receptor antagonist activity and NorAdrenaline Reuptake Inhibitor (NARI) activity is to be administered. The invention further relates to the treatment of at least one symptom of a lower urinary tract disorder in a subject in need of treatment wherein the symptom is selected from the group consisting of urinary frequency, urinary urgency, urinary urge incontinence, nocturia and enuresis, comprising coadministering to said subject a first amount of a 5HT<Sub>3</Sub> antagonist and a second amount of a NARI, wherein the first and second amounts together comprise a therapeutically effective amount or are each present in a therapeutically effective amount.</p> |
申请公布号 |
EP1795196(A3) |
申请公布日期 |
2008.02.06 |
申请号 |
EP20070005612 |
申请日期 |
2004.04.02 |
申请人 |
DYNOGEN PHARMACEUTICALS, INC. |
发明人 |
LANDAU, STEVEN B.;MILLER, CHERYL L.;FRASER, MATTHEW O. |
分类号 |
A61K31/519;A61K31/00;A61K31/135;A61K31/535;A61K31/551;A61K45/06;A61P13/02;A61P13/08;A61P13/10 |
主分类号 |
A61K31/519 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|